Upgrade to SI Premium - Free Trial

Rhythm Pharmaceuticals (RYTM) PT Lowered to $130 at RBC Capital

March 17, 2026 8:13 AM
RBC Capital analyst Lisa Walter lowered the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $130.00 (from $140.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change